Pfizer — 44th Annual J.P. Morgan Healthcare Conference 2026

5 slides from Pfizer's conference presentation, Jan 12, 2026

Slide 1: 44th Annual J.P. Morgan Healthcare Conference
th 44 Annual J.P. Morgan Healthcare Conference January 12, 2026 1
Slide 2: Forward-Looking Statements and Non-GAAP Financial Information
Forward - Looking Statements and Non - GAAP Financial Information • Our discussions during this webcast will include forward-looking statements that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such stateme
Slide 3: Albert Bourla, Chairman and Chief Executive Officer
Albert Bourla Chairman and Chief Executive Officer
Slide 4: 2026 Strategic Priorities
202 6 Strategic Priorities • Maximize value of key transactions • Deliver on critical R&D milestones • Invest to maximize post-2028 growth • Scale AI across our business JPM Healthcare Conference 2026 4
Slide 5: Pfizer Pipeline | Key Recent & Anticipated 2026 Catalysts
Pfizer Pipeline |Key Recent & Anticipated 202 6 Catalysts Regulatory Decisions Data Readouts 20+ Pivotal Study Starts HYMPAVZI (marstacimab) ELREXFIO (elranatamab) Ultra-Long-Acting GLP-1 (PF’3944 / MET-097i)** Hemophilia A/B with Inhibitors Double-class Exposed Relapsed / Refractory Multiple Myelom